- Home
- LPSN vs NVNO Comparison
LPSN vs NVNO Comparison
Compare LPSN & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- NVNO
- Stock Information
- Founded
- LPSN 1995
- NVNO 1987
- Country
- LPSN United States
- NVNO United States
- Employees
- LPSN N/A
- NVNO N/A
- Industry
- LPSN EDP Services
- NVNO Medical/Dental Instruments
- Sector
- LPSN Technology
- NVNO Health Care
- Exchange
- LPSN Nasdaq
- NVNO Nasdaq
- Market Cap
- LPSN 71.2M
- NVNO 61.9M
- IPO Year
- LPSN 2000
- NVNO N/A
- Fundamental
- Price
- LPSN $0.75
- NVNO $2.45
- Analyst Decision
- LPSN Hold
- NVNO
- Analyst Count
- LPSN 5
- NVNO 0
- Target Price
- LPSN $0.98
- NVNO N/A
- AVG Volume (30 Days)
- LPSN 1.3M
- NVNO 94.7K
- Earning Date
- LPSN 05-07-2025
- NVNO 05-07-2025
- Dividend Yield
- LPSN N/A
- NVNO N/A
- EPS Growth
- LPSN N/A
- NVNO N/A
- EPS
- LPSN N/A
- NVNO N/A
- Revenue
- LPSN $312,474,000.00
- NVNO N/A
- Revenue This Year
- LPSN N/A
- NVNO N/A
- Revenue Next Year
- LPSN $29.08
- NVNO $409.09
- P/E Ratio
- LPSN N/A
- NVNO N/A
- Revenue Growth
- LPSN N/A
- NVNO N/A
- 52 Week Low
- LPSN $0.45
- NVNO $2.03
- 52 Week High
- LPSN $2.08
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- LPSN 41.50
- NVNO 44.81
- Support Level
- LPSN $0.72
- NVNO $2.05
- Resistance Level
- LPSN $0.82
- NVNO $2.44
- Average True Range (ATR)
- LPSN 0.08
- NVNO 0.23
- MACD
- LPSN 0.01
- NVNO 0.02
- Stochastic Oscillator
- LPSN 56.00
- NVNO 53.42
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).